DocSym
β
Searchsearch
Search
(Y51.7) Beta-adrenoreceptor antagonists, not elsewhere classified
More details coming soon
17 073 in individuals diagnosis beta-adrenoreceptor antagonists, not elsewhere classified confirmed
507 deaths with diagnosis beta-adrenoreceptor antagonists, not elsewhere classified
3% mortality rate associated with the disease beta-adrenoreceptor antagonists, not elsewhere classified
Diagnosis beta-adrenoreceptor antagonists, not elsewhere classified is diagnosed Men are 43.77% more likely than Women
12 273
Men receive the diagnosis beta-adrenoreceptor antagonists, not elsewhere classified
0 (less than 0.1%)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
4 800
Women receive the diagnosis beta-adrenoreceptor antagonists, not elsewhere classified
507 (10.6 %)Died from this diagnosis.
Risk Group for the Disease beta-adrenoreceptor antagonists, not elsewhere classified - Men aged 70-74 and Women aged 50-54
In Men diagnosis is most often set at age 0-5, 35-39, 50-84
Less common in men the disease occurs at Age 0-1, 5-34, 40-49, 85-95+Less common in women the disease occurs at Age 0-29, 35-49, 55-69, 75-79, 85-95+
In Women diagnosis is most often set at age 30-34, 50-54, 70-74, 80-84
Disease Features beta-adrenoreceptor antagonists, not elsewhere classified
Absence or low individual and public risk
Beta-adrenoreceptor antagonists, not elsewhere classified - what does this mean
Beta-adrenoreceptor antagonists, not elsewhere classified, are a class of drugs that act by blocking the activity of certain chemicals in the body, such as adrenaline, which can cause an increase in heart rate and blood pressure. they work by binding to and blocking the action of beta-adrenergic receptors, which are found on the surface of cells in the heart, lungs, and other organs. by blocking these receptors, the drugs can help to reduce the heart rate and blood pressure, and can be used to treat a variety of cardiovascular conditions.
What happens during the disease - beta-adrenoreceptor antagonists, not elsewhere classified
Beta-adrenoreceptor antagonists, not elsewhere classified, are a group of drugs that block the action of certain hormones in the body. these hormones, known as catecholamines, are involved in the regulation of heart rate, blood pressure, and other body functions. when catecholamines are blocked, the body is unable to regulate these functions properly, resulting in a variety of symptoms such as hypertension, tachycardia, and arrhythmias.
Clinical Pattern
More details coming soon
How does a doctor diagnose
- Physical examination
- Blood tests
- Urine tests
- Imaging tests (such as X-ray, CT scan, MRI)
- Electrocardiogram (ECG)
- Echocardiogram
- Cardiac catheterization
- Stress tests
- Endoscopic tests
- Lung function tests
Treatment and Medical Assistance
Main Goal: Treating the disease Beta-adrenoreceptor antagonists, not elsewhere classified
- Prescribing beta-blockers to reduce the symptoms of the disease
- Administering beta-blockers to reduce the activity of the adrenergic receptors
- Conducting diagnostic tests to assess the severity of the disease
- Prescribing medications to reduce the inflammation caused by the disease
- Recommending lifestyle changes to reduce the risk of complications
- Recommending a diet rich in nutrients to support the body's natural healing process
- Providing psychological support to help patients cope with the physical and emotional effects of the disease
8 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Beta-adrenoreceptor antagonists, not elsewhere classified - Prevention
Beta-adrenoreceptor antagonists, not elsewhere classified, can be prevented by avoiding exposure to known risk factors, such as smoking, high blood pressure, and obesity, and by maintaining a healthy lifestyle with regular physical activity and a balanced diet.